Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.86 1.45%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics EV - Enterprise Value 2011-2024 | RVNC

Annual EV - Enterprise Value Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
972 M 2.98 B 1.25 B 1.48 B 914 M 646 M 770 M 504 M 326 M 157 M 176 M 226 M 195 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.98 B 157 M 815 M